Use of Longstanding the Teophylllne Only or Wlth Beta-2 Agonist in the Chllden With Bronchil Asthma
[BRONŞİAL ASTMALI ÇOCUKLARDA UZUN ETKİLİ TEOFİLİNİN TEK BAŞINA VE BETA-2 AGONİSTLERİ İLE BİRLİKTE KULLANILMASI]
Abstract views: 72 / PDF downloads: 75
DOI:
https://doi.org/10.58600/eurjther.19910102-494Keywords:
Brnochial asthma, theophylline, salbutamolAbstract
Aiming to treat 20 children with bronchial asthma we have used theophylline only and the other {1 O) receied both theophylline and B2 agonist drug. During the study, we serially measured pulmonary functions, oberserved clinical conditions and determined the levels of theohylline. On the da 21 after therapy ended, avarage blood theophyline level qas 8.17.±.17 microgram/ml in the group administered theophylline only. FEV 1 and Vmax25 values have increased to 11.94 and %25, respectively. On the same days, İn the second group which are given both theophylline and agonist increments of the values FEV1 , Vm8Xı5 and Vmax50 have been observed, as %15 and %33 respectively. These finding have shown that bronchodilatator effects of theophylline are augmented when using combined with Beta agonist.
Metrics
References
Hendelles L, Massanar i M, Weinberge r M.: Update on the Pharmacodynamics an d-Pharmacokinetics of Theophyline. Chest (supp1) 88:103, 1985.
Cushley MJ, Tatteresfield AE, Holgate ST.: Adenosine induced bronchocon struclion in Asthma. Am. Rev. Desp. Dis. 129:380, 1984.
Andrew GW, Walter C.: Theophyline Compliance in Asthmatic Children. Annas of Allergy 54:19, 1985.
Rachelefsky GS, Sheldon CS.: Asthma in infant and Children, Treatment of Childhood Asthma. Journal of Allergy and Clinical lmmunology. 76:403, 1985.
Wood AP. Casey R., Kolki GB., et all.: Compliance With Oral Theophyline therapy in Asthmatic children. Annals of Allergy 54:400, 1985.
Klein JJ, Lefkowitz MS, Spektor SL., et all.: Relationship Between Serum Theophyline Levels and Pulmonary function Before and lnhaled Beta Agonist in "Stable" Asthmatics. Am. Rev. Res. Dis. 127: 413, 1983.
Plmmer Al.: The Devlopment of Drug Tolerance to Beta-2 Adrenergic Agent. Chest 73:979, 1983.
Wolfe JD. Taşkın DP., C alvarese B. et a 11.:Bronchodila ıaıor affects of terbutaUn and Aminophyline alone and in combinatio n in Asthmali c Patients. N. Engl. J.Med. 2 98:363, 1978.
Cummıngs NP, Strnk RC. : Combination Drug Therapy in Children Wit h Exercise -lnd uced Bronchospasm. Annals of Aller gy, 53: 395, 1 984.
Şenocak M. Tıbbi istatist ik, Serme! Ma tbaası, 1. Bask ı lst., 1986.
Hıll OH, Jolley ME, Wang CHJ., et all: Fluorescence Polarisation immunoassey. (F.P.I.A) for Theophyline, Clin. Chem. 27:1086, 1981.
Jolley ME, Stroupe SD, Schwenzer KS., et al.: Fluorescence Polarisation lmmunsassey. Clin. Chem. 27:1575, 1981.
Nicholson DP, Chick TGW.: A Re-evaluation of Parenteral Amminophylli"!e. Am. Rev. Resp. Dis. 208: 241, 1973.
Yonkman JHG, Upton AA.: Pharmacokinetics Drug lnteractions With Theophyline. Clin. Pharmacokinet. :309, 1984.
Meddux MS., Leads NH., Organek HW. et all.: The Effect of Erythromcin or theophyline Pharmacokineties at stady State. Chest 81: 563, 1982.
Landay AA, Gonzales MA, Taylor JC.: Effect of Phenobarbital on Theophyline Disposition. J. AII. Clin. 1mm. 62: 27, 1978.
lsles A., Spino M., Tabachinik E. et all: Theophyline Disposition in Cystic Fibrosis. Am. Rev. Resp. Dis. 127:417, 1983.
Mitenko PA, OlgiMe Al.: Rational lntravenous Doses of Theophyline. N. Engl. J. Med. 289: 600, 1973.
Piafsky KM, Olgivie Al.: Dosage of Theophyline in Bronchial Asthma. N. Engl. J. Med. 292: 1218, 1975.
Smith JA., Weber RW, Nelson HS.: Theophyline and Aerosolized Terbutaline in the Treatmenı of Bronchial Asthma. Chest. 78: 816, 1980.
Aydilek R, Bilgiç H, Seber O: Bronşial Astmalı Hastalarda Uzun Etkili Teofilin'in Etkisi ve Beta-2 Reseptör Agonistleri ile Birlikte Kullanılması. 1st. Üni. 9. Kurultayı Bildirileri Kitabı, 4, 1988.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.